Atara Biotherapeutics Inc.
ATRA | NASDAQ
$8.01
-$0.52 (-6.10%)
At close: Oct 30, 2026, 4:00 PM ET
$8.01
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 4:27 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 120.77M | 128.94M | 8.57M | 63.57M | 20.34M | n/a |
Cost of Revenue | 21.21M | 21.01M | 8.89M | 269.99M | 282M | 244.65M |
Gross Profit | 99.56M | 107.93M | -313K | -206.42M | -261.66M | -244.65M |
Operating Income | 35.86M | -83.44M | -276.01M | -280.51M | -340.46M | -309.05M |
Interest Income | 683K | 2.11M | 5.43M | 3.06M | 367K | n/a |
Pretax Income | 32.72M | -85.42M | -276.11M | -228.29M | -340.1M | -306.61M |
Net Income | 32.69M | -85.4M | -276.13M | -228.3M | -340.14M | -306.62M |
Selling & General & Admin | 26.25M | 39.89M | 50.91M | 68.13M | 78.8M | 64.4M |
Research & Development | 37.45M | 151.48M | 224.79M | 272.53M | 282M | 244.65M |
Other Expenses | n/a | n/a | n/a | -266.57M | -282M | -244.65M |
Operating Expenses | 63.7M | 191.37M | 275.69M | 74.1M | 78.8M | 64.4M |
Interest Expense | 3.79M | 4.62M | 5.29M | 373K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 84.91M | 212.38M | 284.58M | 344.09M | 360.8M | 309.05M |
Income Tax Expense | 31K | -12K | 15K | 12K | 46K | 15K |
Shares Outstanding (Basic) | 12.54M | 7.49M | 4.24M | 4.08M | 3.75M | 2.96M |
Shares Outstanding (Diluted) | 12.72M | 7.49M | 4.24M | 4.08M | 3.75M | 2.96M |
EPS (Basic) | 2.61 | -11.41 | -65.18 | -55.96 | -90.78 | -103.63 |
EPS (Diluted) | 2.57 | -11.41 | -65.18 | -55.96 | -90.78 | -103.63 |
EBITDA | 38.63M | -75.75M | -266M | -222.26M | -330.75M | -300.72M |
EBIT | 36.51M | -80.8M | -270.83M | -227.92M | -340.1M | -309.05M |
Depreciation & Amortization | 2.12M | 5.05M | 4.83M | 5.65M | 9.35M | 8.33M |
Add to Watchlist
Select watchlists to add or remove ATRA